SELECTBIO Stem Cells & Cell Therapy Summit is focused on providing an up-to-date expansive view of the current marketplace focused primarily on the latest research and commercial trends in the utility of cells as therapeutics. Included in this definition are cellular therapy and immunotherapy, as well as tissue engineering and regenerative medicine.
The goal of this summit is to bring together speakers presenting different aspects of the business landscape for the broader cellular therapy field and integrating these presentations to provide a comprehensive picture of the current market landscape.
In 2013, our focus in this inaugural summit is on "Stem Cells & Cellular Therapy."
All registered delegates to this summit receive an electronic copy of the SELECTBIO Cellular Therapy, Cord Blood, and iPSCs 2013 Market Report [publication date: January 2013].
Keynote Speakers
Agenda Topics- Cellular Therapy Application Areas
- Commercial Opportunities and Market Analysis
- Cord Blood-derived Stem Cells for Cellular Therapy
- Mesenchymal Stromal Cells for Cellular Therapy
- Regulatory Landscape for Cellular Therapy
- Tissue Engineering
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129
|
SpeakersEnal Razvi, Biotechnology Analyst, SELECTBIO
Marc Martens, Senior Associate, Bird & Bird LLP
Jef Pinxteren, Head, Regenesys
Alison Wilson, Consultant, Cell Data Services
Oliver Boucher, Chief Business Officer, Vivacta Ltd
Luca Romagnoli, Business Development Manager, Areta International
Eric Halioua, Chief Executive Officer, Promethera Biosciences
Edward Balbirnie, COO, Cellectis
|
|
| Exhibition Sponsors | Media Sponsors | | Networking |
| | |  |
|
